As part of its recently published mobile healthcare report, mobile research firm Research2Guidance detailed a study that indicates mHealth has the potential to reduce costs associated with one of the most expensive aspects of our healthcare system: chronic disease care.
In the US alone, chronic disease treatments account for over 80% of all Medicaid and over 95% of all Medicare expenditure. The latest research shows that once large healthcare players begin getting into the mHealth app market, we’ll begin to see a substantial decrease in this cost. The survey, which outlines the therapy fields that offer the best market potential for mHealth solutions, shows that diabetes takes the top spot, followed by obesity, hypertension and coronary heart disease (CHD).
While there are plenty of mHealth apps available, and more being added every day, it will take the entrance of actual, large-scale healthcare providers to truly begin a noticeable shift. While there’s enormous potential for advanced mHealth solutions, there remains several barriers which include regulatory issues and adoption by mainstream healthcare providers — the latter of which being the underlying theme of Research2Guidance’s latest research. For an excellent overview of what the current mHealth market entails and what the future holds, check out mobileStorm’s recent 2011 mHealth Report, which is available here.